Awardee OrganizationWILSON WOLF MANUFACTURING CORPORATION
Description
Abstract Text
DESCRIPTION (provided by applicant): The culture and shipment of islets are an integral part of islet transplant research. Flasks, petri dishes, and bags are the devices used to perform that role. However, these devices have inherent design characteristics that make them poorly suited to the unique needs of islet culture and islet shipping. This results in the use of far too many devices to maintain an islet preparation, a high potential for contamination, severely limited process control, and islet damage during shipping. Unfortunately, little effort has been undertaken to address the problems inherent to existing devices. We propose the creation of a superior device that is ideally suited to oxygenate islets and is tailored to the needs of the islet community. It will be the only device capable of culturing, shipping, and infusing an entire pancreatic islet isolation. This device is referred to as the single layer gas permeable device (SLD). Our investigation is expected to achieve five specific aims. Aim 1 will define a high-density SLD islet culture protocol that provides islets of superior quality and less immunogenicity than possible with existing devices when an entire islet preparation is cultured in a single device for at least seven-days without feeding. Outcomes will be determined by a variety of techniques including oxygen consumption rate (OCR), OCR/DNA, and molecular profiling. Aim 2 will adapt the SLD from a culture to a shipping device. Aim 3 will create a novel gyroscopic shipping container (GSC) that functions as an incubator without need of electronic controls and maintains the SLD in a standing position independent of how its outer container is oriented during shipping. This essentially allows islets to be cultured during shipping. Aim 4 will verify that the SLD of Aim 2 and the GSC of Aim 3 deliver islet tissue with superior viable islet yield, quality, and reduced immunogenicity relative to existing methods. Aim 5 will modify the SLD for islet transfusion and verify the superiority of the SLD for islet culture, shipping, and infusion relative to existing methods.
Project Narrative: Islet transplants hold promise to provide a better quality of life for those afflicted with diabetes and reduce health care cost to society. There are no cell culture devices on the market that are designed with the attributes needed to efficiently oxygenate islets during culture and shipping. This grant is intended to create a gas permeable device (SLD) that can culture, ship, and infuse islets with maximum efficiency.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressCell Culture TechniquesCharacteristicsCommunitiesDevicesDiabetes MellitusElectronicsGasesGrantHealth Care CostsIncubatorsInfusion proceduresInvestigationIslets of LangerhansMarketingMethodsMolecular ProfilingOutcomeOxygen ConsumptionPositioning AttributePreparationProcessProtocols documentationQuality of lifeRelative (related person)ResearchRoleShippingShipsSocietiesTechniquesTissuesTransfusionTransplantationdensitydesignfeedingflasksimmunogenicityisletnovel
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
170969237
UEI
L1HKPVNJ33J8
Project Start Date
30-September-2004
Project End Date
31-March-2011
Budget Start Date
01-April-2009
Budget End Date
31-March-2010
Project Funding Information for 2009
Total Funding
$1,184,237
Direct Costs
$986,912
Indirect Costs
$146,167
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Diabetes and Digestive and Kidney Diseases
$1,184,237
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R44DK069865-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R44DK069865-04
Patents
No Patents information available for 5R44DK069865-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R44DK069865-04
Clinical Studies
No Clinical Studies information available for 5R44DK069865-04
News and More
Related News Releases
No news release information available for 5R44DK069865-04
History
No Historical information available for 5R44DK069865-04
Similar Projects
No Similar Projects information available for 5R44DK069865-04